Publication Date
In 2025 | 0 |
Since 2024 | 0 |
Since 2021 (last 5 years) | 2 |
Since 2016 (last 10 years) | 2 |
Since 2006 (last 20 years) | 2 |
Descriptor
Behavior Modification | 2 |
Behavior Problems | 2 |
Comorbidity | 2 |
Foreign Countries | 2 |
Program Effectiveness | 2 |
Adolescents | 1 |
Age Differences | 1 |
Attention Deficit… | 1 |
Autism | 1 |
Children | 1 |
Cooperative Planning | 1 |
More ▼ |
Author
Publication Type
Journal Articles | 2 |
Information Analyses | 1 |
Reports - Research | 1 |
Education Level
Audience
Location
Netherlands | 2 |
Australia | 1 |
Ireland | 1 |
Switzerland | 1 |
Taiwan | 1 |
United Kingdom | 1 |
United States | 1 |
Laws, Policies, & Programs
Assessments and Surveys
Wechsler Intelligence Scale… | 1 |
What Works Clearinghouse Rating
Tournier, Tess; Wolkorte, Ria; Hendriks, Alexander H. C.; Jahoda, Andrew; Embregts, Petri J. C. M. – Journal of Mental Health Research in Intellectual Disabilities, 2021
Introduction: Families have a significant role in the lives of people with intellectual disabilities and challenging behaviors. However, it is not clear how actively families are involved when people with intellectual disabilities and challenging behaviors are living in out-of-home care. This scoping review explored the frequency and type of…
Descriptors: Family Involvement, Intellectual Disability, Comorbidity, Behavior Problems
Reurts, Eva Enneke; Troost, Pieter W.; Dinnissen, Mariken; Reijnen, Sam; Hoekstra, Pieter J.; Popma, Arne – Journal of Intellectual Disabilities, 2021
A retrospective chart study of patients on open-label aripiprazole treatment was conducted in the Netherlands to add to the knowledge of aripiprazole in children and young adults with mild and borderline intellectual disabilities (IDs). Fifty-three youths, mean age 14.7 ± 3.4 years and mean IQ 64.5 ±13.8, were included. Treatment responders were…
Descriptors: Mild Intellectual Disability, Drug Therapy, Outcomes of Treatment, Foreign Countries